APDN (Applied DNA) Total Business Assets

Official company branding of Applied DNA (APDN)

Applied DNA Sciences (APDN) creates unique biological codes to combat counterfeiting, ensuring the highest level of brand protection. The business relies on the production of linear DNA for medicine and logistics, which minimizes risks by operating across different segments. The company's environmental focus is centered on the strict control of reagents in laboratories. Total assets amount to 69.94, which is supported by the price action chart on GURU.Markets, serving as confirmation of the market valuation.

APDN - Applied DNA Sciences Company Total Assets over the range 07/04/2022 - 10/07/2025
Manufactured product of Applied DNA Sciences Inc

Total assets, reverse-calculated via ROA, reflect the aggregate value of the company's resources, allowing investors to filter out market volatility and determine the fundamental value of the business. By analyzing the dynamics of total assets, one can assess the real scale of Applied DNA Sciences (APDN), whose material base supports the development of PCR technologies for pharmaceuticals and supply chain control systems within the synthetic biology segment.

Main competitors

Total Business Assets TEM|QGEN (Qiagen) - Company Total Assets|Total Business Assets IONS (Ionis Pharmaceuticals, Inc.)|Aggregate Company Assets Repligen Corp. (RGEN)|Avidity Corp - Total Business Assets|Company Total Assets CRSP (CRISPR Therapeutics AG)|Company Total Assets genedx.com WGS|Ultragenyx - Company Total Assets|BEAM - Company Total Assets|Sarepta Therapeutics Inc (SRPT) - Aggregate Company Assets|Total Asset Value of Company TWST (Twist Bioscience Corp)|Aggregate Company Assets 10x Genomics, Inc.|intelliatx.com - Total Asset Value of Company|Aggregate Company Assets Stoke Therapeutics, Inc. (STOK)|Aggregate Company Assets BLFS (BioLife Solutions Inc)|Company Total Assets WVE (Wave Life Sciences Corp)|Company Total Asset Base Maze Therapeutics Corp (MAZE)|Sionna Therapeutics Inc - Company Total Assets|Company Assets primemedicine.com|TSHA: Company Total Assets|Total Business Assets QURE|Cumulative Company Assets MGTX|RGNX: Aggregate Asset Value|Company Total Assets SLDB|ocugen.com - Total Business Assets|Aggregate Company Assets PacBio PACB|BNTC: Total Business Assets|Design Pharma - Company Total Assets|RCKT - Company Total Assets|FDMT (4D Molecular Therapeutics) - Cumulative Company Assets|Lexeo Therapeutics, Inc. - Aggregate Asset Value|Aggregate Company Assets Korro Bio Inc.|Editas Medicine Inc (EDIT) - Company Total Asset Base|Company Total Assets SLN|Cumulative Company Assets proqr.com PRQR|Company Total Assets CDXS (Codexis)|Company Total Asset Base sangamo.com (SGMO)|Nautilus Biotechnology Inc - Company Total Assets|Company Assets Metagenomi Inc.|Precision BioSciences, Inc. (DTIL) - Aggregate Company Assets|Total Business Assets GBIO|BOLD (Boundless Bio, Inc.) - Company Total Assets|Cumulative Company Assets Exicure Corp (XCUR)|Company Total Assets IMNN|PHIO - Company Assets|Aggregate Company Assets Mustang Bio MBIO|Company Total Asset Base TransCode Therapeutics Inc. (RNAZ)|Bionano - Company Total Assets|BLUE - Company Total Assets|immunoprecise.com (IPA) - Aggregate Company Assets|Total Asset Value of Company OMGA (Omega Therapeutics Inc)|OMIC (Singular Genomics Systems Inc) - Company Total Assets|Total Business Assets RGLS (Regulus)|Aggregate Company Assets Syros Pharmaceuticals (SYRS)|telesisbio.com - Total Business Assets|Company Total Assets TCON (TRACON Pharmaceuticals, Inc.)|UBX: Total Business Assets